Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1125054

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1125054

Global Viral Vectors Market 2022-2026

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the viral vectors market and it is poised to grow by $ 490.64 mn during 2022-2026, accelerating at a CAGR of 14.23% during the forecast period. Our report on the viral vectors market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, increasing use of viral vectors to develop gene therapies and vaccines and growing funding for and investments in gene therapies and vaccines.

The viral vectors market analysis includes the application segment and geographic landscape.

Technavio's viral vectors market is segmented as below:

By Application

  • Gene therapy
  • Vaccines

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing number of R&D activities for the development of gene therapies and vaccines using viral vectors as one of the prime reasons driving the viral vector market growth during the next few years. Also, the rising number of M&A and collaborations and the emergence of novel technologies to manufacture viral vectors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the viral vectors market covers the following areas:

  • Viral vectors market sizing
  • Viral vectors market forecast
  • Viral vectors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading viral vectors market vendors that include Batavia Biosciences BV, Bayer AG, Catalent Inc., Creative Biogene, Danaher Corp., F. Hoffmann La Roche Ltd., FinVector Oy, Freeline Therapeutics Holdings plc, FUJIFILM Holdings Corp, Institut Merieux, Lonza Group Ltd., Merck KGaA, Novartis AG, Oxford Biomedica Plc, REGENXBIO Inc, Sirion Biotech GmbH, Takara Holdings Inc, Thermo Fisher Scientific Inc., uniQure NV, and Virovek Inc. Also, the viral vectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40121

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
  • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
  • Exhibit 26: Chart on Comparison by Application
  • Exhibit 27: Data Table on Comparison by Application
  • 5.3 Gene therapy - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
  • 5.4 Vaccines - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Application
  • Exhibit 36: Market opportunity by Application ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 UK - Market size and forecast 2021-2026
  • Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 Japan - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Batavia Biosciences BV
  • Exhibit 85: Batavia Biosciences BV - Overview
  • Exhibit 86: Batavia Biosciences BV - Product / Service
  • Exhibit 87: Batavia Biosciences BV - Key offerings
  • 10.4 Bayer AG
  • Exhibit 88: Bayer AG - Overview
  • Exhibit 89: Bayer AG - Business segments
  • Exhibit 90: Bayer AG - Key offerings
  • Exhibit 91: Bayer AG - Segment focus
  • 10.5 Creative Biogene
  • Exhibit 92: Creative Biogene - Overview
  • Exhibit 93: Creative Biogene - Product / Service
  • Exhibit 94: Creative Biogene - Key offerings
  • 10.6 F. Hoffmann La Roche Ltd.
  • Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.7 FinVector Oy
  • Exhibit 100: FinVector Oy - Overview
  • Exhibit 101: FinVector Oy - Product / Service
  • Exhibit 102: FinVector Oy - Key offerings
  • 10.8 FUJIFILM Holdings Corp
  • Exhibit 103: FUJIFILM Holdings Corp - Overview
  • Exhibit 104: FUJIFILM Holdings Corp - Business segments
  • Exhibit 105: FUJIFILM Holdings Corp - Key offerings
  • Exhibit 106: FUJIFILM Holdings Corp - Segment focus
  • 10.9 Lonza Group Ltd.
  • Exhibit 107: Lonza Group Ltd. - Overview
  • Exhibit 108: Lonza Group Ltd. - Business segments
  • Exhibit 109: Lonza Group Ltd. - Key news
  • Exhibit 110: Lonza Group Ltd. - Key offerings
  • Exhibit 111: Lonza Group Ltd. - Segment focus
  • 10.10 Merck KGaA
  • Exhibit 112: Merck KGaA - Overview
  • Exhibit 113: Merck KGaA - Business segments
  • Exhibit 114: Merck KGaA - Key news
  • Exhibit 115: Merck KGaA - Key offerings
  • Exhibit 116: Merck KGaA - Segment focus
  • 10.11 Oxford Biomedica Plc
  • Exhibit 117: Oxford Biomedica Plc - Overview
  • Exhibit 118: Oxford Biomedica Plc - Business segments
  • Exhibit 119: Oxford Biomedica Plc - Key offerings
  • Exhibit 120: Oxford Biomedica Plc - Segment focus
  • 10.12 Thermo Fisher Scientific Inc.
  • Exhibit 121: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 123: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations
Product Code: IRTNTR40121

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Application - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Application - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Application
  • Exhibits27: Data Table on Comparison by Application
  • Exhibits28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Application ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Batavia Biosciences BV - Overview
  • Exhibits86: Batavia Biosciences BV - Product / Service
  • Exhibits87: Batavia Biosciences BV - Key offerings
  • Exhibits88: Bayer AG - Overview
  • Exhibits89: Bayer AG - Business segments
  • Exhibits90: Bayer AG - Key offerings
  • Exhibits91: Bayer AG - Segment focus
  • Exhibits92: Creative Biogene - Overview
  • Exhibits93: Creative Biogene - Product / Service
  • Exhibits94: Creative Biogene - Key offerings
  • Exhibits95: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits97: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits100: FinVector Oy - Overview
  • Exhibits101: FinVector Oy - Product / Service
  • Exhibits102: FinVector Oy - Key offerings
  • Exhibits103: FUJIFILM Holdings Corp - Overview
  • Exhibits104: FUJIFILM Holdings Corp - Business segments
  • Exhibits105: FUJIFILM Holdings Corp - Key offerings
  • Exhibits106: FUJIFILM Holdings Corp - Segment focus
  • Exhibits107: Lonza Group Ltd. - Overview
  • Exhibits108: Lonza Group Ltd. - Business segments
  • Exhibits109: Lonza Group Ltd. - Key news
  • Exhibits110: Lonza Group Ltd. - Key offerings
  • Exhibits111: Lonza Group Ltd. - Segment focus
  • Exhibits112: Merck KGaA - Overview
  • Exhibits113: Merck KGaA - Business segments
  • Exhibits114: Merck KGaA - Key news
  • Exhibits115: Merck KGaA - Key offerings
  • Exhibits116: Merck KGaA - Segment focus
  • Exhibits117: Oxford Biomedica Plc - Overview
  • Exhibits118: Oxford Biomedica Plc - Business segments
  • Exhibits119: Oxford Biomedica Plc - Key offerings
  • Exhibits120: Oxford Biomedica Plc - Segment focus
  • Exhibits121: Thermo Fisher Scientific Inc. - Overview
  • Exhibits122: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits123: Thermo Fisher Scientific Inc. - Key news
  • Exhibits124: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits125: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!